Sort   by:  
 Page size 
UnknownAddressing Commercial Health determinants: Indigenous Empowerment and Voices for Equity (ACHIEVE)-protocol for a multiphase study.
Not available
S-EPMC12820813 | biostudies-literature
UnknownUnbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies.
Not available
S-EPMC9476467 | biostudies-literature
UnknownThe entomopathogenic bacterial endosymbionts Xenorhabdus and Photorhabdus: convergent lifestyles from divergent genomes.
Not available
S-EPMC3220699 | biostudies-literature
UnknownGenetic correlation between amyotrophic lateral sclerosis and schizophrenia.
Not available
S-EPMC5364411 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
UnknownOutcomes Following Vascular and Endovascular Procedures Performed During the First COVID-19 Pandemic Wave.
Not available
S-EPMC11462031 | biostudies-literature
UnknownQuantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.
Not available
S-EPMC2801744 | biostudies-literature
UnknownAn international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge.
Not available
S-EPMC4073084 | biostudies-literature
UnknownEffects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
Not available
S-EPMC6617509 | biostudies-literature
UnknownEffects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
Not available
S-EPMC7645733 | biostudies-literature
Sort   by:  
 Page size